Form 4: Bellevue Global Life Science Investors LLC Acquires 43,000 Shares of OSR Holdings, Inc. Following Business Combination

Bellevue Global Life Science Investors LLC reports acquiring 43,000 shares of OSR Holdings, Inc. common stock following the conversion of private placement rights related to a business combination.

Summary

• Bellevue Global Life Science Investors LLC acquired 43,000 shares of OSR Holdings, Inc. common stock on February 14, 2025.
• The acquisition resulted from the conversion of 430,000 private placement rights at a price of $0 per share.
• This conversion occurred at the closing of a business combination between Bellevue Life Science Acquisition Corp. and OSR Holdings Co., Ltd.
• Following the transaction, Bellevue Global Life Science Investors LLC directly owns 2,043,500 shares of OSR Holdings, Inc.
• Kuk Hyoun Hwang, as the managing partner of Bellevue Capital Management LLC, holds voting and dispositive power over these shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reflects a standard transaction following a business combination. There are no explicit positive or negative implications evident in the filing.

Industry Context

This transaction reflects activity related to a recent business combination in the life sciences sector, which is a common route for companies to go public. The filing indicates the ownership structure and changes following the merger.

Stakeholder Impact

• The transaction affects shareholders by increasing the number of outstanding shares.
• The transaction provides transparency regarding the ownership structure of OSR Holdings, Inc.

Key Dates

Keywords

OSR Holdings, Bellevue Global Life Science Investors, share acquisition, Form 4, beneficial ownership, business combination, private placement rights, Kuk Hyoun Hwang